Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 169

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Bart J. Biemond, MD PhD, Anil Tombak, MD, Yurdanur Kilinc, MD, Murtadha Al-Khabori, MD, Miguel R. Abboud, MD, Mohammed Nafea, MD, Adlette Inati, MD, Yasser Ahmed Mohamed Soliman Wali, MD, Jens Kristensen, MD PhD, Ellen Donnelly, PhD, John Ohd, MD PhD

Blood (2019) 134 (Supplement_1): 614.

https://doi.org/10.1182/blood-2019-124653

Published: 2019

Journal Articles

Prevalence, Clinical Characteristics and Outcome of Von Willebrand Disease in Oman

Shamsa Alkaabi, Aala Alzadjali, Mustafa Wasifuddin, Ibrahim Suliman Masoud Alghaithi, MD, Murtadha Al-Khabori, MD, Anil Pathare, MD PhD FCPS, MBBS, Yasser Wali, MD

Blood (2019) 134 (Supplement_1): 4939.

https://doi.org/10.1182/blood-2019-123915

Published: 2019

Journal Articles

Overall Survival in Patients with JAK2 and ASXL1 Positive Myeloproliferative Neoplasms

Murtadha Al-Khabori, MD, Shoaib Al-Zadjali, PhD, Iman Al Noumani, Khalil Al Farsi, Salam Al-Kindi, MD, Mohamed Al Huneini, MD, Naglaa Fawaz, MBBChir, MMSc, PhD, Al Lamki Sulayma, MD, Mahdiya Pir Al Bulushi, MD FRCPC, Khalid Al Hashmi, MD, Muna Al Tarshi, MD, Muhanna Almusalhi

Blood (2019) 134 (Supplement_1): 5383.

https://doi.org/10.1182/blood-2019-128309

Published: 2019

Journal Articles

Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review

Miranda Bailey, Megan Gibbs, Nidhi Dani, Ari Mendell, Melissa Thompson

Blood (2019) 134 (Supplement_1): 5867.

https://doi.org/10.1182/blood-2019-131699

Published: 2019

Journal Articles

Fludarabine in Combination with Busulfan As Pretransplant Conditioning for Platelet Gene Therapy in Murine Hemophilia a with Inhibitors

Yingyu Chen, PhD, Jing Li, MD PhD, Jocelyn A. Schroeder, Weiqing Jing, MD PhD, Jianda Hu, PhD, Qizhen Shi, MD PhD

Blood (2019) 134 (Supplement_1): 1108.

https://doi.org/10.1182/blood-2019-127410

Published: 2019

Journal Articles

"Prevalence and Outcome of Avascular Necrosis of the Hip (AVN) Among Young Omani Patients with Sickle Cell Disease"

Iman Al Fadhali, Farah Al-Kindy, MD, Naema Alshibli, Salam Alkindi, FRCP, BA, MBBChir, Murtadha Al-Khabori, MD, Abdulhakim Al Rawas, Asma Al Shezawi, Yasser Mahfouz, Surekha Tony Mevada, Yasser Wali

Blood (2019) 134 (Supplement_1): 3577.

https://doi.org/10.1182/blood-2019-127875

Published: 2019

Journal Articles

Clinical and Magnetic Resonance Imaging (MRI) Decision Making Rules in Differentiating Vaso-Occlusive Crises (VOCs) from Osteomyelitis in Paediatric Sickle Cell Population: Is MRI Pathognomonic?

Ahmed khalifa Al Shukaili, MD, Ahmed Abdullah Al Kharusi, MD, Eyad Tbaileh, MD, Hanan Nazir, Sameer Raniga, Alaa Al Manzalawy, Mohamed Ebrahim Mohamed Ebrahim Elshinawy, MD, Zaid Al Hinai, Laila Al Yazidi, Murtadha Al-Khabori, MD, Yasser Wali

Blood (2019) 134 (Supplement_1): 4824.

https://doi.org/10.1182/blood-2019-130861

Published: 2019

Journal Articles

The Demographic, Clinical and Survival Rate of Classical Hogkings Lymphoma Patients in Oman, Retrospective Study

Khalid Nasser Al Hashmi, Kamla Alwahaibi, Murtadha K. Al-Khabori, BSc, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 5369.

https://doi.org/10.1182/blood-2018-99-114957

Published: 2018

Journal Articles

Evaluation of Endocrine Complications in Beta-Thalassemia Intermedia Patients: A Cross Sectional Multi-Center Study

Blood (2018) 132 (Supplement 1): 2343.

https://doi.org/10.1182/blood-2018-99-110903

Published: 2018

Journal Articles

Combined Effect of By-Pass Agents and a Sequence Identical Analogue of Emicizumab on Fibrin Clot Turbidity and Structure in Factor VIII Deficient Plasma

Iva Pruner, PhD, Yanan Zong, PhDstudent, Nida Mahmoud Hourani Soutari, Roza Chaireti, MD PhD, Aleksandra Antovic, MD PhD, Jovan Antovic, MD PhD

Blood (2018) 132 (Supplement 1): 2473.

https://doi.org/10.1182/blood-2018-99-116112

Published: 2018

Journal Articles

Acquired Secondary Erythrocytosis in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation

Albina Kibirova, Sidra Najeeb, MD, Michael Craig, MD

Blood (2018) 132 (Supplement 1): 3422.

https://doi.org/10.1182/blood-2018-99-113592

Published: 2018

Journal Articles

In Vivo Enrichment of Genetically Manipulated Platelets for Murine Haemophilia B Gene Therapy

Yingyu Chen, PhD, Jocelyn A. Schroeder, Jianda Hu, PhD, Qizhen Shi, MD

Blood (2018) 132 (Supplement 1): 3483.

https://doi.org/10.1182/blood-2018-99-112245

Published: 2018

Journal Articles

Incorporation of Clinical Information to Decipher Driver Mutations in Myeloproliferative Neoplasms

Murtadha K. Al-Khabori, BSc, MD FRCPC,MSc, Shoaib Al-Zadjali, PhD, Mohamed Al-Rawahi, BSc, Iman Al Noumani, Khalil Al Farsi, Salam Al-Kindi, Mohamed Al Huneini, Al Lamki Sulayma, MD, Mahdiya Al-Belushi, MD, Khalid Al Hashmi, MD, Muna Al Tarshi, MD, Muhanna Almusalhi

Blood (2018) 132 (Supplement 1): 5489.

https://doi.org/10.1182/blood-2018-99-118546

Published: 2018

Journal Articles

P53 and CD34 Immunohistochemical Expression on Bone Marrow Biopsy As Predictive Marker of Response to Erythropoietin in Low Risk Myelodysplastic Syndrome

Gianluigi Reda, MD, Francesca Boggio, Sr., MD, Ramona Cassin, MD, Marta Riva, Marco Barella, MD, Alessandro del Gobbo, MD, Laura Bandiera, Emanuela Bonoldi, Alfredo Molteni, MD, Agostino Cortelezzi, MD, Umberto Gianelli, MD

Blood (2018) 132 (Supplement 1): 5511.

https://doi.org/10.1182/blood-2018-99-118811

Published: 2018

Journal Articles

Imetelstat Treatment Leads to Durable Transfusion Independence (TI) in RBC Transfusion-Dependent (TD), Non-Del(5q) Lower Risk MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Who Are Lenalidomide (LEN) and HMA Naive

David P. Steensma, Uwe Platzbecker, Koen Van Eygen, Azra Raza, MD, Valeria Santini, Ulrich Germing, MD, Patricia Font, MD, Irina Samarina, MD, Maria Díez-Campelo, Sylvain Thepot, MD, Edo Vellenga, Mrinal M. Patnaik, MDMBBS, Jun Ho Jang, MD PhD, Jacqueline Bussolari, PhD, Laurie Sherman, BSN, Libo Sun, PhD, Helen Varsos, MS, RPh, Esther Rose, MD, Pierre Fenaux

Blood (2018) 132 (Supplement 1): 463.

https://doi.org/10.1182/blood-2018-99-114877

Published: 2018

Journal Articles

Predictors of Adverse Outcome in Sickle Cell Disease Patients from Oman

Salam Alkindi, FRCP, BA, MBBChir, Salma AlJadidi, Safa Al Adawi, Anil Pathare, MD PhD FCPS, MBBS

Blood (2018) 132 (Supplement 1): 4915.

https://doi.org/10.1182/blood-2018-99-118304

Published: 2018

Journal Articles

Prevalence of Hepatitis B, Hepatitis C and HIV in Sickle Cell Disease Patients from Oman

Salam Alkindi, FRCP, BA, MBBChir, Nada AL-Umairi, Anil Pathare, MD PhD FCPS, MBBS

Blood (2018) 132 (Supplement 1): 4916.

https://doi.org/10.1182/blood-2018-99-118435

Published: 2018

Journal Articles

Risk Factors Predisposing Development of Priapism in Sickle Cell Disease Patients

Salam Alkindi, FRCP, BA, MBBChir, Said AlMufargi, Anil Pathare, MD PhD FCPS, MBBS

Blood (2018) 132 (Supplement 1): 4917.

https://doi.org/10.1182/blood-2018-99-118475

Published: 2018

Journal Articles

Thrombotic Thrombocytopenic Purpura in Oman; Manifestations and Outcome. Retrospective Study

Khalid Nasser Al Hashmi, Samata Al Dowaiki, MD

Blood (2018) 132 (Supplement 1): 5004.

https://doi.org/10.1182/blood-2018-99-115227

Published: 2018

Journal Articles

Avascular Necrosis of the Femoral Head in Sickle Cell Disease in Egypt and Oman: A Cross Sectional Study

Mohsen Saleh Elalfy, MD, Iman Fadhli, Shaimaa Mohammad, Aida Ali, Naema Shibli, Farah Kindi, Sultan Almaskari, Yasser Wali, MD

Blood (2018) 132 (Supplement 1): 4921.

https://doi.org/10.1182/blood-2018-99-116683

Published: 2018

NARROW

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Prevalence, Clinical Characteristics and Outcome of Von Willebrand Disease in Oman

Overall Survival in Patients with JAK2 and ASXL1 Positive Myeloproliferative Neoplasms

Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review

Fludarabine in Combination with Busulfan As Pretransplant Conditioning for Platelet Gene Therapy in Murine Hemophilia a with Inhibitors

"Prevalence and Outcome of Avascular Necrosis of the Hip (AVN) Among Young Omani Patients with Sickle Cell Disease"

Clinical and Magnetic Resonance Imaging (MRI) Decision Making Rules in Differentiating Vaso-Occlusive Crises (VOCs) from Osteomyelitis in Paediatric Sickle Cell Population: Is MRI Pathognomonic?

The Demographic, Clinical and Survival Rate of Classical Hogkings Lymphoma Patients in Oman, Retrospective Study

Evaluation of Endocrine Complications in Beta-Thalassemia Intermedia Patients: A Cross Sectional Multi-Center Study

Combined Effect of By-Pass Agents and a Sequence Identical Analogue of Emicizumab on Fibrin Clot Turbidity and Structure in Factor VIII Deficient Plasma

Acquired Secondary Erythrocytosis in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation

In Vivo Enrichment of Genetically Manipulated Platelets for Murine Haemophilia B Gene Therapy

Incorporation of Clinical Information to Decipher Driver Mutations in Myeloproliferative Neoplasms

P53 and CD34 Immunohistochemical Expression on Bone Marrow Biopsy As Predictive Marker of Response to Erythropoietin in Low Risk Myelodysplastic Syndrome

Imetelstat Treatment Leads to Durable Transfusion Independence (TI) in RBC Transfusion-Dependent (TD), Non-Del(5q) Lower Risk MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Who Are Lenalidomide (LEN) and HMA Naive

Predictors of Adverse Outcome in Sickle Cell Disease Patients from Oman

Prevalence of Hepatitis B, Hepatitis C and HIV in Sickle Cell Disease Patients from Oman

Risk Factors Predisposing Development of Priapism in Sickle Cell Disease Patients

Thrombotic Thrombocytopenic Purpura in Oman; Manifestations and Outcome. Retrospective Study

Avascular Necrosis of the Femoral Head in Sickle Cell Disease in Egypt and Oman: A Cross Sectional Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only